NASDAQ: TRML
Tourmaline Bio Inc Earnings Dates, Reports, Calls

Tourmaline Bio earnings were -$82.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TRML earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$23.0M, up 3.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TRML reported annual earnings of -$73.2M, with 73.8% growth.

TRML earnings history

Current Revenue
$0.0
Current Earnings
-$82.9M
Current Profit Margin
0%

TRML Return on Equity

Current Company
-26.7%
Current Industry
-60.2%
Current Market
31.3%
TRML's Return on Equity (-26.7%)... subscribe to Premium to read more.
High Return on Equity Performance

TRML undefined

Current Company
-26.1%
Current Industry
-2.5%
TRML is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TRML announces earnings.

TRML undefined

Current Company
-29.61%
Current Industry
5.8%
TRML's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TRML vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TRML-$82.67M-$82.87MN/A-$3.22
FTRE-$577.60M-$790.40MN/A-$8.79
ZBION/AN/AN/AN/A
CGEM-$178.31M-$180.07MN/A-$2.66
ATYR-$62.26M-$63.41MN/A-$0.80

Tourmaline Bio Earnings Reports & History FAQ

What were Tourmaline Bio's earnings last quarter?

On TRML's earnings call on Invalid Date, Tourmaline Bio (NASDAQ: TRML) reported Q1 2025 earnings per share (EPS) of -$0.89, up 61.82% year over year. Total TRML earnings for the quarter were -$22.97 million. In the same quarter last year, Tourmaline Bio's earnings per share (EPS) was -$0.55.

If you're new to stock investing, here's how to buy Tourmaline Bio stock.

Is Tourmaline Bio profitable or losing money?

As of the last Tourmaline Bio earnings report, Tourmaline Bio is currently losing money. Tourmaline Bio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$82.87 million, a 72.89% increase year over year.

What was TRML's earnings growth in the past year?

As of Tourmaline Bio's earnings date in Invalid Date, Tourmaline Bio's earnings has grown year over year. TRML earnings in the past year totalled -$82.87 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.